FDA Inspection 969121 — CAF-DAF Scrl
The FDA completed an inspection of CAF-DAF Scrl on Apr 29, 2016 in Brussels. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 29, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Brussels (Belgium)